Vivienne S. Hau, MD, PhD

Dr. Vivienne Hau is a medical and surgical vitreoretinal specialist at the Kaiser Permanente Riverside Medical Center and is the vice area research chair for Riverside on the Southern California Permanente Medical Group’s Regional Research Committee. She is a clinical assistant professor with the Kaiser Permanente Bernard J. Tyson School of Medicine. She founded and directs Kaiser Permanente’s largest ophthalmology prospective clinical trial program. She is the principal investigator of several clinical trials in age-related macular degeneration, diabetic macula edema, and diabetic retinopathy and played a role in helping to bring several ophthalmic therapeutics for FDA approval. Dr. Hau was responsible for the development of an implantable micro-telescope team and helped to establish approval of the ARGUS II retinal prosthesis device. Dr. Hau also investigates the health equity of underrepresented minorities in ophthalmic care and research and is co-chair of the American Society of Retina Specialists Diversity, Equity, and Inclusion Ad-Hoc Committee.

Dr. Hau has co-authored 20 peer-reviewed articles on drug delivery and the genetics of retina diseases in journals such as the New England Journal of Medicine and the Proceedings of the National Academy of Sciences. She also reviews articles for the journal RETINA and the Journal of Vitreoretinal Diseases. Dr. Hau holds several leadership positions with the American Society of Retina Specialists and American Academy of Ophthalmology.